Wendy Buzo Perez
Family · Calexico, CANPI 1518696319
Payments from drug & device makers
Across 109 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$424
- Novo Nordisk$381
- Corcept Therapeutics$352
- Lilly USA, LLC$164
- Xeris Pharmaceuticals, Inc.$164
- Amgen$97
- plus $607 from 15 others
What the payments were for
- Food & beverage$2,188100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $424 |
| Novo Nordisk | 29 | $381 |
| Corcept Therapeutics | 15 | $352 |
| Lilly USA, LLC | 10 | $164 |
| Xeris Pharmaceuticals, Inc. | 8 | $164 |
| Amgen | 6 | $97 |
| Bayer | 4 | $92 |
| GSK | 4 | $82 |
| Novartis | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 2 | $62 |
| Ironwood Pharmaceuticals, Inc | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Boehringer Ingelheim | 2 | $33 |
| Cequr Corporation | 1 | $31 |
| Recordati_rare_diseases_inc. | 1 | $26 |
| Shield Therapeutics Inc | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Medtronic | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
How this compares
$2,188 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 239 | $230,206 |
| FarxigaDapagliflozin Propanediol | 108 | $80,579 |
| LinzessLinaclotide | 74 | $45,633 |
| JanuviaSitagliptin Phosphate | 45 | $43,244 |
| RybelsusSemaglutide | 27 | $37,277 |
| JardianceEmpagliflozin | 44 | $33,324 |
| TrulicityDulaglutide | 32 | $28,549 |
| ProliaDenosumab | 17 | $27,759 |
| TradjentaLinagliptin | 29 | $24,529 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $12,453 |
| VascepaIcosapent Ethyl | 33 | $12,453 |
| Bydureon BciseExenatide Microspheres | 13 | $9,856 |
| MyrbetriqMirabegron | 20 | $9,010 |
| DapagliflozinDapagliflozin Propanediol | 17 | $8,847 |
| EliquisApixaban | 15 | $8,451 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $381 | $267,484266 claims |
| AstraZenecaFarxiga | $424 | $80,579108 claims |
| Boehringer IngelheimJardiance, Tradjenta | $33 | $57,85373 claims |
| Lilly USA, LLCTrulicity | $164 | $28,54932 claims |
| AmgenProlia | $97 | $27,75917 claims |
| GSKTrelegy Ellipta | $82 | $12,45321 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $46 | $5,21211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Calexico
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.